In summary, our novel findings show that downregulation of RIF1 could not only inhibit cancer cells proliferation and migration but also enhance cisplatin-induced growth inhibition, G2/M cell cycle arrest, apoptosis and DNA damage in cervical cancer, suggesting that RIF1 may be a novel strategy for cervical cancer therapy. This evidence concerns the gene RIF1 and cervical carcinoma.